| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5815357 | Neuropharmacology | 2013 | 6 Pages |
Abstract
⺠Drug treatments of cognitive deficits in schizophrenia have had limited success. ⺠Cognitive remediation training approaches involve considerable time requirements. ⺠Nicotinic agonists can facilitate sensory processing, attention, learning and memory. ⺠Effects constitute an ideal effects profile for enhancing training benefits. ⺠Coupling cognitive training with nicotinic agonists may accelerate training effects.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Britta Hahn, James M. Gold, Robert W. Buchanan,